rp2,nivolumab,rp-1
replimune,bms
['rp2 ', 'ignyte', 'replimune', '$repl']
replimune group shares updated data from ignyte clinical trial and phase 1 trial of rp2 at asco annual meeting. $repl #biotech #oncolytic #immunotherapies #positive 
Real-time news analysis & sentiment scoring (+/-) for stocks
Powered by @streetbeat_com
From the creators of @uscongbuysnews
Disclosure: https://t.co/eNe8LEd7CU